{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:18:57Z","timestamp":1792451937383,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1124\/mol.108.047035","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T01:41:05Z","timestamp":1207273265000},"page":"20-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells"],"prefix":"10.1016","volume":"74","author":[{"given":"Venkatesh L.","family":"Hegde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne J.","family":"Hofseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitzi","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash S.","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.047035_REF1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1053\/jhep.2003.50459","article-title":"Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis","volume":"38","author":"Biswas","year":"2003","journal-title":"Hepatology"},{"key":"10.1124\/mol.108.047035_REF2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0192-0561(86)90020-2","article-title":"In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells","volume":"8","author":"Blanchard","year":"1986","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/mol.108.047035_REF3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4049\/jimmunol.172.1.45","article-title":"Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis","volume":"172","author":"Bonder","year":"2004","journal-title":"J Immunol"},{"key":"10.1124\/mol.108.047035_REF4","unstructured":"Center for Drug Evaluation and Research (2002) Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Food and Drug Administration, Rockville, MD. Available at: http:\/\/www.fda.gov\/cber\/gdlns\/dose.htm"},{"key":"10.1124\/mol.108.047035_REF5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/faat.1996.0048","article-title":"Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice","volume":"30","author":"Chan","year":"1996","journal-title":"Fundam Appl Toxicol"},{"key":"10.1124\/mol.108.047035_REF6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.bjp.0706699","article-title":"Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms","volume":"148","author":"Chang","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.108.047035_REF7","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.4049\/jimmunol.166.10.5889","article-title":"CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death","volume":"166","author":"Chen","year":"2001","journal-title":"J Immunol"},{"key":"10.1124\/mol.108.047035_REF8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/mol.108.047035_REF9","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.108.047035_REF10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1124\/mol.108.047035_REF11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023","article-title":"Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?","volume":"166","author":"Croxford","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1124\/mol.108.047035_REF12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/mol.108.047035_REF13","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1124\/mol.108.047035_REF14","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.173.4.2373","article-title":"Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation","volume":"173","author":"Do","year":"2004","journal-title":"J Immunol"},{"key":"10.1124\/mol.108.047035_REF15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.21498","article-title":"IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice","volume":"45","author":"Erhardt","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/mol.108.047035_REF16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1124\/mol.108.047035_REF17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20020190","article-title":"Interleukin 2 signaling is required for CD4(+) regulatory T cell function","volume":"196","author":"Furtado","year":"2002","journal-title":"J Exp Med"},{"key":"10.1124\/mol.108.047035_REF18","first-page":"190","article-title":"Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor","volume":"21","author":"Gantner","year":"1995","journal-title":"Hepatology"},{"key":"10.1124\/mol.108.047035_REF19","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4049\/jimmunol.174.6.3344","article-title":"Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities","volume":"174","author":"Haeryfar","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/mol.108.047035_REF20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.108.047035_REF21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic role of the cannabinoid receptor CB2 in the liver","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.108.047035_REF22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/taap.1996.8049","article-title":"Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo","volume":"142","author":"Kamath","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.108.047035_REF23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1142265","article-title":"Attenuation of allergic contact dermatitis through the endocannabinoid system","volume":"316","author":"Karsak","year":"2007","journal-title":"Science"},{"key":"10.1124\/mol.108.047035_REF24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/mol.108.047035_REF25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/gast.2001.22441","article-title":"The lymphoid liver: considerations on pathways to autoimmune injury","volume":"120","author":"Kita","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.108.047035_REF26","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.4049\/jimmunol.164.12.6461","article-title":"Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection","volume":"164","author":"Klein","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/mol.108.047035_REF27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","article-title":"Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A","volume":"111","author":"K\u00fcsters","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.108.047035_REF28","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1053\/gast.2002.33620","article-title":"Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice","volume":"122","author":"Louis","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.108.047035_REF29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","article-title":"Cannabinoid receptors as therapeutic targets","volume":"46","author":"Mackie","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.108.047035_REF30","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1152\/ajpgi.00467.2007","article-title":"Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver","volume":"294","author":"Mallat","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.108.047035_REF31","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1046\/j.1432-1033.2002.03078.x","article-title":"Presence and regulation of the endocannabinoid system in human dendritic cells","volume":"269","author":"Matias","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1124\/mol.108.047035_REF32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","article-title":"Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo","volume":"302","author":"McKallip","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.108.047035_REF33","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/mol.108.047035_REF34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.108.047035_REF35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.108.047035_REF36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.108.047035_REF37","doi-asserted-by":"crossref","first-page":"G850","DOI":"10.1152\/ajpgi.00523.2007","article-title":"Endocannabinoid effects on immune cells: implications for inflammatory liver diseases","volume":"294","author":"Pacher","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.108.047035_REF38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"10.1124\/mol.108.047035_REF39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0163-7258(02)00255-3","article-title":"Cannabinoids and multiple sclerosis","volume":"95","author":"Pertwee","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.108.047035_REF40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00000542-200310000-00031","article-title":"Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors","volume":"99","author":"Quartilho","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.108.047035_REF41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0952-7915(95)80114-6","article-title":"Activation-induced death of mature T cells in the regulation of immune responses","volume":"7","author":"Russell","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"10.1124\/mol.108.047035_REF42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)64804-3","article-title":"Importance of Kupffer cells for T-cell-dependent liver injury in mice","volume":"157","author":"Sch\u00fcmann","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1124\/mol.108.047035_REF43","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1096\/fj.06-7717com","article-title":"The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species","volume":"21","author":"Siegmund","year":"2007","journal-title":"FASEB J"},{"key":"10.1124\/mol.108.047035_REF44","doi-asserted-by":"crossref","first-page":"G357","DOI":"10.1152\/ajpgi.00456.2007","article-title":"Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis","volume":"294","author":"Siegmund","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.108.047035_REF45","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1074\/jbc.M509706200","article-title":"Fatty acid amide hydrolase determines anandamide-induced cell death in the liver","volume":"281","author":"Siegmund","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.108.047035_REF46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"10.1124\/mol.108.047035_REF47","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4049\/jimmunol.159.3.1418","article-title":"Suppression of concanavalin A-induced hepatitis in IFN-gamma(-\/-) mice, but not in TNF-alpha(-\/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes","volume":"159","author":"Tagawa","year":"1997","journal-title":"J Immunol"},{"key":"10.1124\/mol.108.047035_REF48","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.108.047035_REF49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat Med"},{"key":"10.1124\/mol.108.047035_REF50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.108.047035_REF51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24049034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24049034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.047035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:55:43Z","timestamp":1739966143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24049034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0026895X24049034"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.047035","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.047035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}